Gabapentin (GBP) is a widely used antiepileptic drug, with potential for use in the treatment of epilepsy in pregnant women. Although studies have examined GBP transport mechanisms across the blood-brain barrier, kidney, and intestine, the mechanism in the placenta has not been fully elucidated. We previously reported that GBP accumulates at high concentrations in human placental choriocarcinoma BeWo cells. The purpose of this study was to examine the transport mechanism of GBP in placental choriocarcinoma cells (BeWo and JEG-3), and to identify the carrier involved.
Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan Phone/Fax: +81-11-706-3770; E-mail: ken-i@pharm.hokudai.ac.jp GBP withdrawal syndrome after prolonged in utero exposure [8] . Therefore, information on the 20 transport mechanisms of antiepileptic drugs in placental cell models might contribute to estimate the 21 adverse effect of these drugs on the fetus. However, little information is available on the transport 22 mechanism of GBP in placental cell models. 23 Ohman et al. [9] reported that umbilical-to-maternal GBP plasma concentration ratios 24 ranged from 1.3 to 2.1 (mean, 1.7), implying that the drug is actively transported across the 25 near-term placenta. GBP is a zwitterion and the distribution coefficient (LogD, pH 7.4) has 26 previously been reported to be −1.2 [10] . Therefore, a carrier-mediated mechanism might be 27 involved in its transport across the plasma membrane. We previously reported that the accumulation 28 of GBP in human placental choriocarcinoma BeWo cells occurred in higher concentrations than in 29 other new-generation antiepileptic drugs such as LTG, LEV, and TPM [11] . Furthermore, the 30 transport of GBP in BeWo cells showed saturation at high concentrations, suggesting that the 31 transfer of GBP to choriocarcinoma cells is carrier-mediated. 32 Membrane transporters play a role in the pharmacokinetic and physiological processes in 33 several organs, including the placenta. Over 400 membrane transporters have been identified and 34 classified as ATP-binding cassettes (ABC) and solute carriers (SLC). While taking into 35 consideration individual variation, it is crucial to examine the role of drug transporters in the 36 placenta in order to prevent potential drug-drug interactions. In brain endothelial cells, GBP is 37 transported by L-type amino acid transporter 1 (LAT1, SLC7A5) [10] . The organic cation/carnitine transporter (OCTN1, SLC22A4) contributes to the urinary excretion of GBP, with its genetic variant 39 L503F resulting in decreased GBP transport [12] . Larsen et al. [13] suggest that in the intestine, a 40 carrier-mediated system, which is inhibited by 2-Amino-2-norbornanecarboxylic acid (BCH), 41 contributes to the transport of GBP in a rat model and in Caco-2 cells. System L transporter LAT1 42 catalyzes the sodium-independent transport of physiologically important substrates such as amino 43 acids [14] and thyroid hormones [15] , and is highly expressed in the placenta [16] . OCTN1 is an 44 important transporter for various xenobiotics, and endogenous substrates such as L-carnitine, and is 45 expressed in the placenta [17, 18] . However, there is limited literature on studies investigating the 46 involvement of these transporters in the uptake of GBP in placental cell lines. 47 In the present study, we investigated the uptake mechanism of GBP in human placental was determined using a Pierce ® BCA Protein Assay Kit (Thermo Scientific, Rockford, IL), in 94 accordance with the manufacturer's instructions. To investigate intracellular concentration of GBP, intracellular water volumes of BeWo 98 and JEG-3 cells were estimated using modified methods described by Rottenberg et al. [21] and 99 Shiraya et al. [22] . BeWo cells and JEG-3 cells were seeded on 24-well collagen-coated plastic 100 plates. After removal of growth medium, cells were washed with a transport buffer and 101 pre-incubated with 0.5 mL of buffer. The buffer was removed and 0.5 mL of buffer containing 102 [ 3 H]-H 2 O (1 µCi/mL) (PerkinElmer, Boston, MA), and [ 14 C]inulin-carboxyl (0.5 µCi/mL) 103 (American Radiolabeled Chemicals, Inc. St. Louis, MO) was added to cells. The cells were 104 incubated in the buffer for 10 min. The extracellular buffer was collected, and cells were solubilized 105 with 1 % sodium dodecyl sulfate (SDS)/0.2 N NaOH. The samples were mixed with 3 mL of 106 scintillation cocktail (PerkinElmer) to measure radioactivity using a liquid scintillation counter. 114 JEG-3 cells were seeded (1 × 10 5 cells/cm 2 ) in a 24-well Transwell TM (Pore Size, 0.4 115 µm) (Corning, Kennebunk, ME) and grown for eight days. After removal of growth medium, cells 116 were washed with transport buffer and pre-incubated at 37 °C with transport buffer (apical side, 0.1 117 mL; basolateral side, 0.6 mL). After removal of incubation buffer, transport buffer containing GBP 118 (50 µM) in the absence or presence of BCH (1 mM) was added to apical side or basolateral side.
Transepithelial transport of GBP across JEG-3 cells

119
The monolayers were incubated for 30 min at 37 °C. After incubation, an aliquot was collected from 120 the basolateral side or the apical side. The concentration of GBP was quantified using LC/MS/MS.
121
The apparent permeability coefficient (P app ) was calculated using the following equation:
where dQ/dt is the linear appearance rate of mass in the receiver solution, A is the filter/cell surface 124 area (0.33 cm 2 ), and C 0 is the initial donor concentration of substrate (50 µM). Beverly, MA) supplemented with 1 mM PMSF. The suspension was allowed to stand for 5 min on 137 ice and was sonicated briefly. The suspension was then centrifuged at 14,000 × g for 10 min at 4 °C.
138
The supernatant was used for Western blotting. The protein concentration was determined using a Statistical significance among means of more than two groups was evaluated using Dunnett's test.
170
Statistical significance was defined as p < 0.05.
171
Nonlinear regression analysis was performed using Origin® (OriginLab Corporation, MA). Kinetic 172 parameters were calculated using the following equation:
where v is the uptake rate of compounds, s is the compound concentration, K m is the 175 Michaelis-Menten constant, and V max is the maximum uptake rate.
176
The IC 50 value was determined by fitting the dose-response data in DoseResp equation 189 We previously reported that GBP accumulates in BeWo cells in higher concentrations than 190 other antiepileptic drugs, such as LTG, LEV, and TPM [11] . In the present study, the accumulation 191 levels of these drugs in JEG-3 cells were investigated. As shown in Table 1 , after incubation with 50 192 µM of the antiepileptic drugs for 30 min at 37 °C, the cellular accumulation was as follows: GBP > 193 LTG > LEV ≈ TPM. The tendency for these drugs to accumulate in JEG-3 cells was consistent with 194 the results in BeWo cells.
Uptake mechanism of GBP in choriocarcinoma JEG-3 cell line
195
Subsequently, uptake mechanism of GBP in JEG-3 cells was investigated. Figure 1A shows 196 the time-dependent uptake of GBP by JEG-3 cells following incubation with 5 µM GBP. The uptake 197 of GBP occurs in a linear fashion for the first 10 min; hence, the initial uptake was evaluated at 5 198 min. The transport of GBP in JEG-3 cells exhibited saturation at high concentrations (Fig. 1B) . The 199 uptake of GBP at 4 °C was lower than that at 37 °C. Eadie-Hofstee plots (inset in Fig. 1B ) showed a 200 single straight line. The kinetic parameters, K m and V max are calculated and summarized in Table 2 . 203 Previous reports suggest that OCTN1 and LAT1 may contribute to the transport of GBP in 204 other tissues. To elucidate the involvement of these transporters in the placenta, the effects of (TEA), quinidine, and cimetidine are OCTN inhibitors, while BCH is a LAT inhibitor. As shown in 207 Fig. 2 (A), OCTN inhibitors (1 mM) had no significant effect on GBP uptake in BeWo cells; 208 however, BCH (1 mM) decreased GBP uptake ( Fig. 2(B) ). Furthermore, BCH inhibited the uptake 209 of GBP in a concentration-dependent manner. The IC 50 value was calculated as 0.113 ± 0.02 mM.
Effects of OCTN and LAT inhibitors on GBP uptake
210
These results suggest GBP uptake in BeWo cells is mediated by a BCH-sensitive system. 
Effects of LAT1 knockdown on GBP uptake 213
To evaluate the specific role of LAT1, the effect of LAT1 knockdown by siRNA was 214 investigated. In this study, three different siRNA constructs targeting the LAT1 gene were used. In 
Amino acids and thyroid hormones inhibit GBP uptake in choriocarcinoma cells
221
Neutral amino acids and thyroid hormones, which are important for fetal development, are 222 substrates of LAT1. The effects of amino acids and thyroid hormones on the uptake of GBP were 4A). Thr, Ser, Gln, and Asn also significantly inhibited GBP uptake. When compared to the control, 226 thyroid hormones T 3 and T 4 inhibited GBP uptake by 35 and 64 %, respectively (Fig. 4B ). The 227 inhibitory effect of T 3 was higher than that of T 4 . 230 To assess the possibility of drug-drug interactions in the placenta, the effects of 231 antiepileptic drugs on GBP uptake were investigated. As shown in Table 3 To investigate the transepithelial transport of GBP, JEG-3 cells were seeded on Transwell.
Effects of antiepileptic drugs on GBP uptake in choriocarcinoma cells
238
The apparent permeability coefficient (P app ) of apical to basolateral GBP transport was 5.62 ± 0.64 239 (× 10 -6 cm/s) (n=3), and that of basolateral to apical GBP transport was 4.96 ± 0.76 (× 10 -6 cm/s) 240 (n=3).
241
The apical to basolateral transport of GBP was not significantly different from the basolateral to 
Discussion
246
Since antiepileptic drugs must across the blood-brain barrier to exert their pharmacological 247 effects, ideally the substrate should be delivered to the brain, while keeping mother-to-fetus passage 248 across the placenta to a minimum [24] . Therefore, evaluating the involvement of transporters in the 249 transport process of antiepileptic drugs across the placenta may lead to the development of better 250 and safer antiepileptic drugs for pregnant women. GBP is an approved drug for the treatment of 251 epilepsy. GBP is also used for neuropathic pain and restless legs syndrome [25, 26] . Information 252 regarding the safety and risk of GBP administration during pregnancy is required in order for 253 pregnant patients to be fully informed. Active placental transport of GBP was suggested by Ohman 254 et al. [9] because of the high umbilical-to-maternal GBP plasma concentration ratio (mean, 1.7).
255
Placenta expresses a variety of influx and efflux transporters. However, little information is 256 currently available on the detailed mechanisms underlying the transport of GBP in placental cell 257 model. In the present study, we investigated the transport mechanism of GBP in choriocarcinoma 258 cell lines, BeWo and JEG-3.
259
The cellular accumulation of antiepileptic drugs in JEG-3 cells after incubation, occurred as 260 follows GBP > LTG > LEV ≈ TPM (Table 1) . This tendency was consistent with BeWo cells as we 261 previously reported [11] . The extent of intracellular accumulation in the choriocarcinoma cells did 262 not correlate with the hydrophobicity of each compound. The uptake mechanism of GBP was investigated in the present study, as the drug is present in high concentrations in choriocarcinoma 264 cells, despite its hydrophilicity. Although the transport mechanisms of GBP in the blood-brain in the placenta [16, 18] , and this study investigated the involvement of these transporters in GBP 270 transport.
271
Our previous study indicated that the transport of GBP in BeWo cells reached saturation at 272 high concentrations, suggesting a carrier-mediated pathway [11] . The transport of GBP in JEG-3 273 cells followed saturation kinetics. Eadie-Hofstee plots showed single straight lines for both cell lines 274 (BeWo, [11] ;, JEG-3, Fig. 1B) , signifying a single carrier-mediated mechanism in the uptake of 275 GBP. The K m values were calculated as 105.4 ± 6.4 µM for BeWo cells [11] , and 123.7 ± 22 µM for 276 JEG-3 cells ( Table 2) . These values are similar to those obtained in LAT1-overexpressing HEK293 277 cells (K m = 217 µM) [10] . The carrier has the potential to contribute to the transport of GBP, as the 278 reference range for GBP plasma concentration varies approximately between 10-120 µM [20] . It 279 has been reported that K m value of OCTN1 for GBP is 417 µM [27] . 280 Knockdown studies revealed that LAT1 is involved in the transport of GBP in both BeWo and 283 JEG-3 cells (Fig. 3) . Furthermore, GBP transport was significantly inhibited by the biological 284 substrates of LAT transporter, such as neutral amino acids and thyroid hormones. Amino acids, 285 including Trp, Phe, Tyr, Leu, Ile, Val, Met, Cys, and His, strongly inhibited GBP uptake (Fig. 4A ).
286
The inhibitory effects of the amino acids were in accordance with the substrate selectivity of LAT1
287
[16]. The present study indicated that the inhibitory effect of T 3 was higher than that of T 4 (Fig. 4B) .
288
It has been reported that the affinity of LAT1 for T 3 is higher than that for T 4 (K m values of 0.8 µM 289 for T 3, and 7.9 µM for T 4 ) [28] . These results further suggest that LAT1 is the main contributor to 290 the transport of GBP in choriocarcinoma cells.
291
The estimated value of the kinetic parameter V max in BeWo cells was approximately twice 292 as high as that obtained from JEG-3 cells ( Table 2) . Western blot analysis showed that the 293 expression of LAT1 in BeWo cells was higher than its expression in JEG-3 cells (Supplemental 294 Fig.1) . These results suggest that the expression level of LAT1 affects the uptake capacity of BeWo 295 and JEG-3 cells. It has been reported that the expression of LAT1 is higher in primary 296 cytotrophoblasts isolated from human placenta than in differentiated syncytiotrophoblasts [29] .
297
BeWo cells resemble undifferentiated cytotrophoblasts, and JEG-3 cells possess many of the 298 biological and biochemical characteristics of syncytiotrophoblasts [19] . With respect to LAT1 299 expression, these cell lines may display a similar trend to that observed in primary cells. and JEG-3 cells (Supplemental Fig. 2 ). However, typical inhibitors of OCTN1, including 302 L-carnitine, TEA, quinidine, and cimetidine, had no significant effect on GBP uptake ( Fig. 2A) . It 303 has been reported that L-carnitine, TEA, quinidine, and cimetidine significantly decreased the 304 OCTN1-mediated [ 14 C]TEA transport in HEK293 cells [30] . Although mRNA expression of 305 OCTN1 was observed, the function of OCTN1 in placental cell lines might be low. Previous studies 306 reported strong expression of OCTN1 in kidney, skeletal muscle, bone marrow, and trachea [18] .
307
Weaker expression of OCTN1 was observed in placenta [18] . On the other hand, strong expression 308 of OCTN2 was observed in placenta [18] . Furthermore, several groups have reported the functional 309 expression of the OCTN2 in BeWo cells [31, 32] . Therefore, the function of OCTN2 might be more 310 prominent than OCTN1 in placenta.
311
In the present study, we also investigated the transcellular transport of GBP using JEG-3 312 cells grown on Transwell. The apical to basolateral transport reduced by approximately 25 % by the 313 coexistence of BCH. On the other hand, the basolateral to apical transport remained unchanged in 314 the co-presence of BCH. This result may indicate that LAT1 expression in the basolateral membrane 315 in JEG-3 is low. Gacciol et al. [33] reported that LAT1 protein is highly distributed in the 316 microvillus plasma membranes of the human term placenta, but it is not detected in the basolateral 317 membrane. Although it is not clear yet, passive diffusion or other mechanisms, may contribute to 318 basolateral to apical transport. It has been reported that umbilical cord-to-maternal plasma 319 concentration of GBP ratios ranged from 1.3 to 2.1 (mean, 1.7) [9] . However, the ratio of apical to basolateral transport/basolateral to apical transport was approximately 1.1. In the present study, cells were calculated to be 5.12 ± 0.22 μL/mg protein and 4.83 ± 0.82 μL/mg protein, respectively.
333
The concentrations of GBP in BeWo and JEG-3 cells after 60 min incubation with 5 µM of GBP 334 were 3045 ± 328 pmol/mg protein for BeWo cells [11] and 2465 ± 188 pmol/mg protein for JEG-3 335 cells (Fig. 1A) . Therefore, intracellular concentrations of GBP were estimated to be 595 ± 64 μM 336 for BeWo cells and 510 ± 39 μM for JEG-3 cells. The results indicated that GBP accumulated in 337 these cell lines. LAT1 is Na + -independent and obligatory exchanger [14] . It transports amino acid been reported that LAT1 can actively uptake amino acid substrate by functionally coupling with 340 other amino acid transporter [35] . Leu transport by LAT1 is dependent on Gln that is actively 341 delivered into cells by Na + -dependent amino acid transporter ASCT2 (SLC1A5). LAT1 therefore 342 mediates the active influx of Leu into cells coupled to the efflux of intracellular Gln. Furthermore, it 343 has been reported that the intracellular affinities of LAT1 for amino acids are lower than the 344 extracellular affinities [36] . Therefore, GBP accumulation in placental choriocarcinoma cell line 345 may be attributed to the transport properties of LAT1. Future studies are required to investigate the 346 detailed mechanism of active transport of GBP in placental choriocarcinoma cell by LAT1.
347
Recently, it has been reported that several antiepileptic drugs alter the expression of 348 placental transporters, including that of LAT1 [37] . In the present study, we investigated whether 349 GBP uptake in choriocarcinoma cells is affected by the co-presence of other antiepileptic drugs.
350
Coexistence of antiepileptic drugs did not strongly affect GBP uptake in BeWo cells (Table 3) . 351 These results suggest that these antiepileptic drugs do not directly affect LAT1 function and the 352 transport of GBP remains unchanged when other antiepileptic drugs are concurrently administered, 353 although the effect of long-term treatment is unclear. On the other hand, the present study indicated 354 that the biological substrates of LAT1, including thyroid hormones and several amino acids, 355 inhibited GBP transport in BeWo cells (Fig. 4) . The results imply that plasma levels of these 356 substrates may affect the transport of GBP, while simultaneously; the transport of these biological 357 substrates may be inhibited by GBP. In previous reports, higher rates of preterm births and low birth weights were documented in pregnant mothers using GBP [7] . Future studies should investigate the 359 possible association between fetal health risks and the transport mechanism of GBP.
360
It has been reported that the umbilical-to-maternal GBP plasma concentration ratio ranges 361 from 1.3 to 2.1, as found in a study with a small sample size of 6 women [9] . Single nucleotide 362 polymorphisms have also been known to occur in LAT1 (SLC7A5). It has been reported that an 363 SLC7A5 polymorphism rs4240803 is associated with gastrointestinal toxicity of melphalan, which is 364 transported by LAT1 [38] . Future studies should investigate the effects of polymorphisms on the 365 variability of GBP transfer in the placenta.
366
In summary, the current study was undertaken to investigate the uptake mechanism of GBP, 367 an antiepileptic drug that accumulates in the choriocarcinoma cells, BeWo and JEG-3, in high 368 concentrations. Our results indicated that the transport of GBP in choriocarcinoma cells was 369 carrier-mediated and involved LAT1. Furthermore, GBP transport was modulated by the 370 co-presence of LAT biological substrates, such as large neutral amino acids and thyroid hormones.
371
To the best of our knowledge, this is the first study investigating the transport mechanism of GBP 372 and the contribution of transporters in choriocarcinoma cell lines, BeWo and JEG-3. Although these 373 cell lines have been widely used to examine the transport mechanism of xenobiotics in placenta, 374 these cell lines differ from the normal placental trophoblast. The extrapolation of findings observed 375 in choriocarcinoma cells to normal trophoblast must be made with caution. Further investigations 376 are required to elucidate the involvement of LAT1 in the transport of GBP in normal trophoblast. 
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